Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaper

Showing results (511-520 of 532) with videos related to

Pageof 54
Sort By:
Plos One|July 23, 2013
Serine protease EspP from enterohemorrhagic Escherichia coli is sufficient to induce shiga toxin macropinocytosis in intestinal epitheliumJulie In, Valeriy Lukyanenko, Jennifer Foulke-Abel, et al.
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|September 5, 2008
IPCRG Consensus statement: tackling the smoking epidemic - practical guidance for primary careOnno C P van Schayck, Hilary Pinnock, Anders Ostrem, et al.
Blood|August 18, 2010
Improvement in hematological, visceral, and skeletal manifestations of Gaucher disease type 1 with oral eliglustat tartrate (Genz-112638) treatment: 2-year results of a phase 2 studyElena Lukina, Nora Watman, Elsa Avila Arreguin, et al.
Cancer Research|June 3, 2006
Connective tissue growth factor-specific monoclonal antibody therapy inhibits pancreatic tumor growth and metastasisNadja Dornhöfer, Suzanne Spong, Kevin Bennewith, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|February 26, 2014
Nasal endoscopy is recommended for diagnosing adults with chronic rhinosinusitisAnnemarie M H Wuister, Namiko A Goto, E J Oostveen, et al.
Blood|May 5, 2010
A phase 2 study of eliglustat tartrate (Genz-112638), an oral substrate reduction therapy for Gaucher disease type 1Elena Lukina, Nora Watman, Elsa Avila Arreguin, et al.
Science Translational Medicine|June 1, 2012
Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNATim Forshew, Muhammed Murtaza, Christine Parkinson, et al.
Plos Pathogens|June 21, 2013
The Escherichia coli phosphotyrosine proteome relates to core pathways and virulenceAnne-Marie Hansen, Raghothama Chaerkady, Jyoti Sharma, et al.
Plos One|February 21, 2012
Highly parallel genome-wide expression analysis of single mammalian cellsJian-Bing Fan, Jing Chen, Craig S April, et al.
Science Translational Medicine|July 3, 2020
Circulating transcripts in maternal blood reflect a molecular signature of early-onset preeclampsiaSarah Munchel, Suzanne Rohrback, Carlo Randise-Hinchliff, et al.
Pageof 54

Showing results (511-520 of 532) with videos related to

Sort By:
Pageof 54
Plos One|July 23, 2013
Serine protease EspP from enterohemorrhagic Escherichia coli is sufficient to induce shiga toxin macropinocytosis in intestinal epitheliumJulie In, Valeriy Lukyanenko, Jennifer Foulke-Abel, et al.
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|September 5, 2008
IPCRG Consensus statement: tackling the smoking epidemic - practical guidance for primary careOnno C P van Schayck, Hilary Pinnock, Anders Ostrem, et al.
Blood|August 18, 2010
Improvement in hematological, visceral, and skeletal manifestations of Gaucher disease type 1 with oral eliglustat tartrate (Genz-112638) treatment: 2-year results of a phase 2 studyElena Lukina, Nora Watman, Elsa Avila Arreguin, et al.
Cancer Research|June 3, 2006
Connective tissue growth factor-specific monoclonal antibody therapy inhibits pancreatic tumor growth and metastasisNadja Dornhöfer, Suzanne Spong, Kevin Bennewith, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|February 26, 2014
Nasal endoscopy is recommended for diagnosing adults with chronic rhinosinusitisAnnemarie M H Wuister, Namiko A Goto, E J Oostveen, et al.
Blood|May 5, 2010
A phase 2 study of eliglustat tartrate (Genz-112638), an oral substrate reduction therapy for Gaucher disease type 1Elena Lukina, Nora Watman, Elsa Avila Arreguin, et al.
Science Translational Medicine|June 1, 2012
Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNATim Forshew, Muhammed Murtaza, Christine Parkinson, et al.
Plos Pathogens|June 21, 2013
The Escherichia coli phosphotyrosine proteome relates to core pathways and virulenceAnne-Marie Hansen, Raghothama Chaerkady, Jyoti Sharma, et al.
Plos One|February 21, 2012
Highly parallel genome-wide expression analysis of single mammalian cellsJian-Bing Fan, Jing Chen, Craig S April, et al.
Science Translational Medicine|July 3, 2020
Circulating transcripts in maternal blood reflect a molecular signature of early-onset preeclampsiaSarah Munchel, Suzanne Rohrback, Carlo Randise-Hinchliff, et al.
Pageof 54